Laura Kerby has been appointed as the next chief executive of Prostate Cancer UK.
Kerby, who has been chief executive of the cancer charity Myeloma UK since April 2020, will succeed Angela Culhane, who will retire at the end of this year.
Culhane has spent almost eight years at Prostate Cancer UK, having joined the cancer charity as director of finance in January 2014. She became interim chief executive in October 2015 and was appointed to the job permanently the following February.
Before joining Myeloma UK, Kerby spent six years as chief executive of the cancer support charity Penny Brohn UK. Prior to that she was managing director of Nuffield Health for almost 15 years.
“My father is one of the 400,000 men in the UK living with a prostate cancer diagnosis and I am determined to ensure future lives are neither shortened nor limited by the disease,” said Kerby.
“Every aspect of my career has been driven by health and wellbeing. I have worked strategically across the healthcare landscape in prevention, diagnostic, treatment and living well with disease. I passionately believe that working together, uniting the best science and clinical practice means that ultimately, we will be able to beat prostate cancer.”
Kerby will take up the role on 28 February.
Prostate Cancer UK said Nicola Tallett, its director of fundraising and supporter engagement, would be interim chief executive.
Charles Packshaw, chair of Prostate Cancer UK, said: “Laura’s extensive experience in both the charity world and the wider business world make her the ideal person to lead us forward as we work towards our vision of a future where lives are not limited by prostate cancer.
“I also want to thank Angela Culhane for her outstanding work at Prostate Cancer UK over the past eight years.
“She leaves the charity in a fantastic position to build on the transformational change she has overseen during her time in the role.”